Physician profile
James E Harris
NPI 1548281306
$4,707.43
in general payments reported to CMS, 2019-2025
13 companies · $1,025 in 2025
The $1,025 reported for 2025 was more than what 91% of Optometrist providers received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $920 · 2020: $352 · 2021: $321 · 2022: $570 · 2023: $592 · 2024: $928 · 2025: $1,025.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,493 · Entertainment: $51.08.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,493.07 |
| Entertainment | $51.08 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $1,739.42 | 2019-2025 | Clareon, Unity, Lensx |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $856.74 | 2019-2021 | |
| Bausch & Lomb Americas INC. | $693.03 | 2022-2025 | Infuse, Biotrue One Day |
| Coopervision INC. | $442.20 | 2020-2025 | Myday Contact Lens, Clariti Contact Lens |
| Optos, INC. | $258.98 | 2019-2025 | Panoramic Ophthalmoscope, Oct Ophthalmoscope, Nfc-700 |
| Topcon Healthcare, INC. | $210.95 | 2023 | |
| Visionary Optics LLC | $147.83 | 2024 | |
| Maculogix, INC. | $109.43 | 2021 | |
| Biotissue Holdings INC. | $93.88 | 2025 | |
| Synergeyes, INC. | $52.93 | 2019 | |
| Abbvie INC. | $41.08 | 2023 | |
| Carl Zeiss Meditec USA, INC. | $40.91 | 2021 | |
| Johnson & Johnson Vision Care, INC. | $20.05 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw James Harris listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.